Doyle William F (CIK 0001194459)

Latest company ownership

NVCR - NovoCure Ltd
Role: Chair
Shares held
551,176
Last filed at
Aug 3, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2016Q2 2025Q4
Shares held
94,499
Last filed at
Dec 3, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2024Q1 2025Q4
Shares held
2,500
Last filed at
Jun 28, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2018Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 21, 2024 May 23, 2024 Elanco Animal Health Inc Director Buy 97.5 +15,000 24.46% ✗ $254.7K
Mar 8, 2024 Mar 12, 2024 Elanco Animal Health Inc Director Buy 95.0 +15,000 32.38% ✗ $244.5K
Aug 2, 2022 Aug 3, 2022 NovoCure Ltd Chair Sell 47.5 -837 -0.15% ✗ $58.3K
Mar 8, 2022 Mar 9, 2022 NovoCure Ltd Chair Sell 47.5 -2,385 -0.43% ✗ $167.2K
Aug 2, 2021 Aug 4, 2021 NovoCure Ltd Chair Sell 47.5 -995 -0.18% ✗ $148.6K
Apr 13, 2021 Apr 15, 2021 NovoCure Ltd Chair Sell 17.5 -95,000 -14.61% ✓ $19M
Mar 31, 2021 Apr 2, 2021 NovoCure Ltd Chair Sell 37.5 -7,928 -1.20% ✗ $1.1M
Jul 31, 2020 Aug 3, 2020 NovoCure Ltd Chair Sell 47.5 -896 -0.14% ✗ $68.4K
May 11, 2020 May 12, 2020 NovoCure Ltd Chair Sell 37.5 -31,332 -4.60% ✗ $2M
May 7, 2020 May 11, 2020 NovoCure Ltd Chair Sell 37.5 -62,896 -4.50% ✗ $4M
May 5, 2020 May 7, 2020 NovoCure Ltd Chair Sell 37.5 -60,164 -9.58% ✗ $3.8M
Mar 6, 2020 Mar 10, 2020 NovoCure Ltd Chair Sell 42.5 -4,320 -0.84% ✗ $300.4K
Feb 27, 2020 Mar 2, 2020 NovoCure Ltd Chair Sell 42.5 -3,893 -0.75% ✗ $281.1K
Jan 17, 2020 Jan 22, 2020 NovoCure Ltd Chair Sell 7.5 -133,777 -20.80% ✓ $12.7M
Nov 25, 2019 Nov 26, 2019 NovoCure Ltd Chair Sell 17.5 -16,223 -2.46% ✗ $1.6M
Nov 20, 2019 Nov 22, 2019 NovoCure Ltd Chair Sell 12.5 -150,000 -18.53% ✓ $13.6M
Nov 11, 2019 Nov 13, 2019 NovoCure Ltd Chair Sell 17.5 -43,000 -5.04% ✗ $3.5M
Jun 27, 2019 Jul 1, 2019 Minerva Neurosciences, Inc. Director Buy 91.3 +3,500 15.48% ✗ $19.3K
May 30, 2019 Jun 3, 2019 NovoCure Ltd Chair Sell 17.5 -48,100 -5.38% ✗ $2.6M
May 29, 2019 May 31, 2019 NovoCure Ltd Chair Sell 40.0 -1,900 -0.21% ✗ $100.9K
May 9, 2019 May 10, 2019 NovoCure Ltd Chair Sell 37.5 -31,460 -3.39% ✗ $1.5M
May 7, 2019 May 9, 2019 NovoCure Ltd Chair Sell 37.5 -64,316 -3.62% ✗ $3.1M
May 6, 2019 May 7, 2019 NovoCure Ltd Chair Sell 37.5 -29,038 -3.44% ✗ $1.4M
May 2, 2019 May 6, 2019 NovoCure Ltd Chair Sell 37.5 -29,966 -3.67% ✗ $1.4M
Feb 27, 2019 Mar 1, 2019 NovoCure Ltd Chair Sell 47.5 -3,097 -0.34% ✗ $166.2K
Dec 20, 2018 Dec 26, 2018 Minerva Neurosciences, Inc. Director Buy 86.3 +2,000 9.70% ✗ $13K
Dec 10, 2018 Dec 12, 2018 Minerva Neurosciences, Inc. Director Buy 91.3 +6,000 41.06% ✗ $47.8K
Nov 20, 2018 Nov 21, 2018 Minerva Neurosciences, Inc. Director Buy 91.3 +2,000 15.86% ✗ $16.4K
Oct 11, 2018 Oct 15, 2018 Minerva Neurosciences, Inc. Director Buy 82.5 +600 5.00% ✗ $6K
Sep 17, 2018 Sep 19, 2018 Minerva Neurosciences, Inc. Director Buy 91.3 +1,800 17.63% ✗ $18.9K
Sep 13, 2018 Sep 17, 2018 Minerva Neurosciences, Inc. Director Buy 91.3 +2,200 27.46% ✗ $23.1K
Sep 10, 2018 Sep 11, 2018 Minerva Neurosciences, Inc. Director Buy 95.0 +8,011 100.00% ✗ $78.5K
May 8, 2018 May 10, 2018 NovoCure Ltd Chair Sell 37.5 -57,408 -3.50% ✗ $1.6M
May 4, 2018 May 8, 2018 NovoCure Ltd Chair Sell 37.5 -57,470 -3.39% ✗ $1.6M
May 2, 2018 May 4, 2018 NovoCure Ltd Chair Sell 40.0 -28,519 -1.65% ✗ $795.3K
Feb 28, 2017 Mar 2, 2017 NovoCure Ltd Chair Sell 17.5 -572,725 -1.43% ✗ $4.4M
May 6, 2016 May 10, 2016 NovoCure Ltd Director Sell 17.5 -243,357 -1.12% ✗ $3.1M